Newspaper article Manchester Evening News

Pioneering Treatment for Cancer

Newspaper article Manchester Evening News

Pioneering Treatment for Cancer

Article excerpt

NHS patients with a form of cancer will have access to a "game-changing" new treatment, it has been announced.

A deal between NHS England and manufacturer Gilead Sciences means up to 200 adults per year will be able to receive CAR-T therapy axicabtagene ciloleucel.

The treatment, also known as Yescarta, offers new hope to patients with a type of lymphoma who have run out of other options and may have just months left to live.

Last month, a separate deal was secured to make a form of CAR-T therapy available to children and young people with a rare type of leukaemia.

CAR-T therapy, described as "one of the most promising new treatments in a generation for lymphoma and leukaemia", is a personalised treatment that reprogrammes immune system cells to target the cancer. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.